The company
Italfarmaco is an international pharmaceutical group with a long-standing presence in drug development and commercialisation. The company operates globally and is currently experiencing significant growth within the rare disease and specialty pharmaceutical sectors.
The Context
Italfarmaco is currently seeking a Patent Attorney to join its Corporate IP function based in Milan, Italy.
This newly created position reflects the increasing strategic importance of intellectual property within the organisation as the company continues to grow internationally and expand its pharmaceutical portfolio.
The Role
The position sits within Italfarmaco’s in-house IP team and offers broad exposure across key intellectual property activities, including invention harvesting, patent drafting, prosecution, freedom-to-operate analyses and portfolio strategy.
The successful candidate will work closely with scientific and R&D teams while supporting high-value pharmaceutical assets and ongoing innovation activities.
The role also offers exposure to international patent matters, enforcement-related activities and the opportunity to contribute to the establishment of internal IP processes and ways of working.
The candidate
The ideal candidate should have:
- Experience within pharmaceutical, biotechnology or chemistry-related IP
- Strong patent drafting and prosecution experience
- Experience with FTO analyses and patent strategy
- Scientific background in Chemistry, Biochemistry, Biology, Pharmacy or related field
- CEIPI or equivalent IP qualification
- EQE qualification or currently undertaking qualification
- Strong communication skills in English
- Italian language proficiency is strongly preferred given the close interaction with local R&D and business stakeholders
- Ability to work autonomously in a collaborative international environment
- Commercially minded, pragmatic and comfortable operating in an evolving organisation
- Ability to act as a strategic support and thought partner to the Senior IP Director, contributing to the continued development of the IP function
For a confidential discussion, please contact Christopher Adamson, Samantha Knowles or Nicolas Philippe.
